These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Smoking cessation interventions for smokers with current or past depression. van der Meer RM; Willemsen MC; Smit F; Cuijpers P Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776 [TBL] [Abstract][Full Text] [Related]
28. Effects of nicotine versus placebo e-cigarette use on symptom relief during initial tobacco abstinence. Perkins KA; Karelitz JL; Michael VC Exp Clin Psychopharmacol; 2017 Aug; 25(4):249-254. PubMed ID: 28650184 [TBL] [Abstract][Full Text] [Related]
29. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Anthenelli RM; Benowitz NL; West R; St Aubin L; McRae T; Lawrence D; Ascher J; Russ C; Krishen A; Evins AE Lancet; 2016 Jun; 387(10037):2507-20. PubMed ID: 27116918 [TBL] [Abstract][Full Text] [Related]
30. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. George TP; Vessicchio JC; Termine A; Bregartner TA; Feingold A; Rounsaville BJ; Kosten TR Biol Psychiatry; 2002 Jul; 52(1):53-61. PubMed ID: 12079730 [TBL] [Abstract][Full Text] [Related]
33. A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care. Fossati R; Apolone G; Negri E; Compagnoni A; La Vecchia C; Mangano S; Clivio L; Garattini S; Arch Intern Med; 2007 Sep; 167(16):1791-7. PubMed ID: 17846399 [TBL] [Abstract][Full Text] [Related]
34. Mediators of the effect of nicotine pre-treatment on quitting smoking. Hajek P; Lewis S; Munafo M; Lindson N; Coleman T; Aveyard P; Addiction; 2018 Dec; 113(12):2280-2289. PubMed ID: 30066385 [TBL] [Abstract][Full Text] [Related]
35. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. Evins AE; Culhane MA; Alpert JE; Pava J; Liese BS; Farabaugh A; Fava M J Clin Psychopharmacol; 2008 Dec; 28(6):660-6. PubMed ID: 19011435 [TBL] [Abstract][Full Text] [Related]
36. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223 [TBL] [Abstract][Full Text] [Related]
37. Bupropion and naltrexone for smoking cessation: A double-blind randomized placebo-controlled clinical trial. Mooney ME; Schmitz JM; Allen S; Grabowski J; Pentel P; Oliver A; Hatsukami DK Clin Pharmacol Ther; 2016 Oct; 100(4):344-52. PubMed ID: 27213949 [TBL] [Abstract][Full Text] [Related]
38. Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion. Wileyto EP; Patterson F; Niaura R; Epstein LH; Brown RA; Audrain-McGovern J; Hawk LW; Lerman C Nicotine Tob Res; 2005 Apr; 7(2):257-68. PubMed ID: 16036283 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642 [TBL] [Abstract][Full Text] [Related]
40. Potential sex differences in the pattern of sensory reinforcers enhanced by nicotine. Perkins KA; Karelitz JL Exp Clin Psychopharmacol; 2016 Jun; 24(3):156-61. PubMed ID: 27124265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]